Highly Active Antiretroviral Therapy Pedram SendiAndrew J. PalmerManuel Battegay Leading Article 23 September 2012 Pages: 709 - 713
A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs Sherine E. GabrielDouglas CoyleLarry W. Moreland Review Article 23 September 2012 Pages: 715 - 728
Economic and Health-Related Quality of Life Considerations of New Therapies in Parkinson’s Disease Linda M. RubensteinAndrea DeLeoElizabeth A. Chrischilles Review Article 23 September 2012 Pages: 729 - 752
Emerging Role of Pharmacoeconomics in the Research and Development Decision-Making Process Joseph A. DiMasiErol CaglarcanMaria Wood-Armany Original Research Article 23 September 2012 Pages: 753 - 766
Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries Ola GhatnekarUlf PerssonKnut Ödegaard Original Research Article 23 September 2012 Pages: 767 - 778
Iatrogenic Cost Factors Incorporating Mild and Moderate Adverse Events in the Economic Comparison of Aceclofenac and Other NSAIDs Francesc PerisEduard MartínezMax Brosa Original Research Article 23 September 2012 Pages: 779 - 790